Fractionated Stem Cell Infusions for Patients with Plasma Cell Myeloma Undergoing Autologous Hematopoietic Cell Transplantation

類似資料

• Patterns of Relapse and Progression in Multiple Myeloma Patients after Autologous Stem Cell Transplantation: Implications for Patients’ Monitoring After Transplantation
  著者:: Zamarin, Dmitriy, 等
  出版事項: (2012)
• CD34-selected allogeneic hematopoietic stem cell transplantation for patients with relapsed, high-risk multiple myeloma
  著者:: Smith, Eric, 等
  出版事項: (2015)
• Re-vaccination following Autologous Hematopoietic Stem Cell Transplantation is Safe and Effective in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance
  著者:: Palazzo, Meighan, 等
  出版事項: (2017)
• Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantation
  著者:: Shah, Gunjan L., 等
  出版事項: (2017)
• Upfront Use of Plerixafor and Granulocyte-Colony Stimulating Factor (GCSF) for Stem Cell Mobilization in Patients with Multiple Myeloma: Efficacy and Analysis of Risk Factors Associated with Poor Stem Cell Collection Efficiency
  著者:: Ogunniyi, Adebayo, 等
  出版事項: (2016)